BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12364549)

  • 1. Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    J Lipid Res; 2002 Oct; 43(10):1652-60. PubMed ID: 12364549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential cholesteryl ester acceptors among triglyceride-rich lipoproteins during alimentary lipemia in normolipidemic subjects.
    Lassel TS; Guérin M; Auboiron S; Chapman MJ; Guy-Grand B
    Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):65-74. PubMed ID: 9445258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin reduces postprandial accumulation and cholesteryl ester transfer protein-mediated remodeling of triglyceride-rich lipoprotein subspecies in type IIb hyperlipidemia.
    Guerin M; Egger P; Le Goff W; Soudant C; Dupuis R; Chapman MJ
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4991-5000. PubMed ID: 12414863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a cholesteryl ester donor activity of LDL particles during alimentary lipemia in normolipidemic subjects.
    Lassel TS; Guerin M; Auboiron S; Guy-Grand B; Chapman MJ
    Atherosclerosis; 1999 Nov; 147(1):41-8. PubMed ID: 10525123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities.
    Mero N; Van Tol A; Scheek LM; Van Gent T; Labeur C; Rosseneu M; Taskinen MR
    J Lipid Res; 1998 Jul; 39(7):1493-502. PubMed ID: 9684753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial chylomicrons: potent vehicles for transporting cholesterol from endogenous LDL+HDL and cell membranes to the liver via LCAT and CETP.
    Chung BH; Liang P; Doran S; Cho BH; Franklin F
    J Lipid Res; 2004 Jul; 45(7):1242-55. PubMed ID: 15102891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB hyperlipidemia.
    Julia Z; Duchene E; Fournier N; Bellanger N; Chapman MJ; Le Goff W; Guerin M
    J Lipid Res; 2010 Nov; 51(11):3350-8. PubMed ID: 20713650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
    Chung BH; Segrest JP; Franklin F
    Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potencies of lipoproteins in fasting and postprandial plasma to accept additional cholesterol molecules released from cell membranes.
    Chung BH; Franklin F; Cho BH; Segrest JP; Hart K; Darnell BE
    Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1217-30. PubMed ID: 9714128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.
    Guérin M; Le Goff W; Lassel TS; Van Tol A; Steiner G; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):282-8. PubMed ID: 11156866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma.
    Yen FT; Deckelbaum RJ; Mann CJ; Marcel YL; Milne RW; Tall AR
    J Clin Invest; 1989 Jun; 83(6):2018-24. PubMed ID: 2723070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux.
    Guerin M; Le Goff W; Frisdal E; Schneider S; Milosavljevic D; Bruckert E; Chapman MJ
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3738-46. PubMed ID: 12915663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cholesteryl ester synthesis, cholesteryl ester transfer protein concentration and activity in hypercholesterolemic women: effects of the degree of saturation of dietary fatty acids in the fasting and postprandial states.
    Lottenberg AM; Nunes VS; Lottenberg SA; Shimabukuro AF; Carrilho AJ; Malagutti S; Nakandakare ER; McPherson R; Quintão EC
    Atherosclerosis; 1996 Oct; 126(2):265-75. PubMed ID: 8902152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
    Artery; 1993; 20(1):1-18. PubMed ID: 8447724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia.
    Guérin M; Bruckert E; Dolphin PJ; Turpin G; Chapman MJ
    Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):763-72. PubMed ID: 8640404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma.
    Murakami T; Michelagnoli S; Longhi R; Gianfranceschi G; Pazzucconi F; Calabresi L; Sirtori CR; Franceschini G
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1819-28. PubMed ID: 7583561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of cholesteryl ester transfer protein-mediated cholesteryl ester mass transfer from high-density lipoprotein to low-density lipoprotein particles is a major feature of combined hyperlipidaemia.
    Guérin M; Bruckert E; Dolphin PJ; Chapman MJ
    Eur J Clin Invest; 1996 Jun; 26(6):485-94. PubMed ID: 8817163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transfer.
    Channon KM; Clegg RJ; Bhatnagar D; Ishola M; Arrol S; Durrington PN
    Atherosclerosis; 1990 Jan; 80(3):217-26. PubMed ID: 2310427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias.
    Iglesias A; Contreras JA; Martínez-Pardo M; Entrala A; Herrera E; Lasunción MA
    Clin Chim Acta; 1993 Nov; 221(1-2):73-89. PubMed ID: 8149644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.